Price-Volatility Risk on Investment Securities
First written in FY2016. 9 of 32 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2027-H1.
The whole theme swung hardest in 2019: 57 of 139 companies on the "Worse" side.
- FY2027-H1WorsenedAnnual report
「Investment securities 1,676,996 1,940,239」
The balance of investment securities increased from ¥1,676.996 million at the end of the previous fiscal year to ¥1,940.239 million, expanding the amount exposed to the impact of price declines. - FY2026WorsenedAnnual report
「Investments in securities 1,676,996」
The balance of investment securities increased from ¥1,175 million at the end of the previous fiscal year to ¥1,677 million, and the valuation difference on available-for-sale securities was also ¥927 million. The amount exposed to the impact of falling prices has increased. - FY2026-H1Updated the interim valuation differenceAnnual report
「Valuation difference on available-for-sale securities 589,389 677,076」
The valuation difference on available-for-sale securities increased by ¥87.686 million, from ¥589.389 million at the end of the previous consolidated fiscal year to ¥677.076 million, updating the valuation position of investment securities in response to price fluctuations. - FY2025MitigatedAnnual report
「Issues with a decrease in the number of shares during the fiscal year Unlisted shares 1 1,540 Shares other than unlisted shares 2 142,989」
The Company sold shares in 2 listed issues classified as cross-shareholdings, for sale proceeds of ¥142.989 million. The balance-sheet amount of listed shares also decreased to ¥1,154.549 million. - FY2025-H1MitigatedAnnual report
「Proceeds from the sale of investment securities 142,530」
The Company sold ¥142.530 million of investment securities, partially reducing the price fluctuation risk associated with holding them. Meanwhile, the valuation difference on available-for-sale securities decreased by ¥79.159 million. - FY2024WorsenedAnnual report
「As a rule, the Group holds marketable shares and other securities at the request of business partners and others with which it has business relationships, with holdings of ¥1,239 million at the end of the consolidated fiscal year. If share prices or other market prices fall substantially in the future, impairment losses may arise, adversely affecting the Group's results and potentially lowering its equity ratio.」
Year-end holdings of marketable shares and other securities were ¥1,239 million, updating the amount exposed to the impact of falling share prices. - FY2024-Q3Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 530,561 616,225」
The valuation difference on available-for-sale securities increased from ¥530.561 million at the end of the previous consolidated fiscal year to ¥616.225 million, updating the valuation position of investment securities in response to price fluctuations. - FY2024-Q2Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 530,561 638,623」
The valuation difference on available-for-sale securities increased by ¥108.062 million, from ¥530.561 million at the end of the previous consolidated fiscal year to ¥638.623 million, updating the valuation position of investment securities in response to price fluctuations. - FY2024-Q1Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 530,561 591,923」
The valuation difference on available-for-sale securities increased from ¥530.561 million at the end of the previous consolidated fiscal year to ¥591.923 million, updating the valuation position of investment securities in response to price fluctuations. - FY2023-Q3Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 373,146 450,207」
The valuation difference on available-for-sale securities increased from ¥373.146 million at the end of the previous consolidated fiscal year to ¥450.207 million, updating the valuation position of investment securities in response to price fluctuations. - FY2023-Q2Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 373,146 383,532」
The valuation difference on available-for-sale securities increased from ¥373.146 million at the end of the previous consolidated fiscal year to ¥383.532 million, updating the valuation impact of price fluctuations in investment securities. - FY2023-Q1Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 373,146 387,558」
The valuation difference on available-for-sale securities increased from ¥373.146 million at the end of the previous consolidated fiscal year to ¥387.558 million, updating the valuation impact of price fluctuations in investment securities. - FY2022MaterialisedAnnual report
「During the consolidated fiscal year, the Company recognized an impairment loss of ¥26.672 million on shares classified as other securities.」
An impairment loss of ¥26.672 million arising from price fluctuations in investment securities was actually recognized. Meanwhile, holdings of marketable shares and other securities at the end of the fiscal year were ¥987 million. - FY2022-Q3Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 422,304 404,371」
The valuation difference on available-for-sale securities decreased from ¥422.304 million at the end of the previous consolidated fiscal year to ¥404.371 million, updating the valuation impact of price fluctuations in investment securities. - FY2022-Q2Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 422,304 414,057」
The valuation difference on available-for-sale securities decreased by ¥8.247 million, from ¥422.304 million at the end of the previous consolidated fiscal year to ¥414.057 million, updating the valuation position at the end of the quarter. - FY2022-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities 422,304 387,021」
The valuation difference on available-for-sale securities decreased from ¥422.304 million at the end of the previous consolidated fiscal year to ¥387.021 million, with the valuation impact of price fluctuations in investment securities actually materializing. - FY2021WorsenedAnnual report
「As a rule, the Group holds marketable shares and other securities at the request of business partners and others with which it has business relationships, with holdings of ¥1,083 million at the end of the consolidated fiscal year. If share prices or other market prices fall substantially in the future, impairment losses may arise」
The disclosure states that holdings of marketable shares and other securities at the end of the fiscal year were ¥1,083 million, an increase from the previous fiscal year's level in the amount exposed to the impact of falling prices. - FY2021-Q3MaterialisedAnnual report
「Loss on valuation of investment securities — 2,012」
A ¥2.012 million loss on valuation of investment securities was recognized, with losses arising from price fluctuations in investment securities actually materializing. Meanwhile, the valuation difference on available-for-sale securities increased by ¥111.503 million from the end of the previous consolidated fiscal year. - FY2021-Q2Updated the quarterly valuation differenceAnnual report
「Valuation difference on available-for-sale securities 217,796 275,248」
The valuation difference on available-for-sale securities increased by ¥57.451 million, from ¥217.796 million at the end of the previous consolidated fiscal year to ¥275.248 million, updating the valuation position at the end of the quarter. - FY2021-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 217,796 261,284」
The valuation difference on available-for-sale securities increased from ¥217.796 million at the end of the previous consolidated fiscal year to ¥261.284 million, an improvement from the decline in the valuation difference through the previous fiscal year. - FY2020MitigatedAnnual report
「Valuation difference on available-for-sale securities (down ¥195 million year on year)」
While a valuation impact on investment securities occurred, the valuation difference on available-for-sale securities decreased by ¥195 million, and holdings of marketable shares and other securities at the end of the consolidated fiscal year also fell to ¥792 million. - FY2020-Q3MaterialisedAnnual report
「Valuation difference on available-for-sale securities 413,180 442,375」
The valuation difference on available-for-sale securities increased from ¥413.180 million at the end of the previous consolidated fiscal year to ¥442.375 million, with the valuation impact of price fluctuations in investment securities actually materializing. - FY2020-Q2MaterialisedAnnual report
「Valuation difference on available-for-sale securities 413,180 344,893」
The valuation difference on available-for-sale securities decreased by ¥68.287 million, from ¥413.180 million at the end of the previous consolidated fiscal year to ¥344.893 million, with the valuation impact of price fluctuations in investment securities actually materializing. - FY2020-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities 413,180 352,004」
The valuation difference on available-for-sale securities decreased by ¥61.176 million, from ¥413.180 million at the end of the previous consolidated fiscal year to ¥352.004 million, with the valuation impact of price fluctuations actually materializing. - FY2019MaterialisedAnnual report
「Valuation difference on available-for-sale securities (down ¥175 million year on year)」
The valuation difference on available-for-sale securities decreased by ¥175 million from the end of the previous fiscal year, and the valuation impact of price fluctuations in investment securities continued to materialize. The balance of investment securities was ¥1,094.782 million. - FY2019-Q3MaterialisedAnnual report
「Valuation difference on available-for-sale securities 589,175 363,431」
The valuation difference on available-for-sale securities decreased by ¥225.743 million, from ¥589.175 million at the end of the previous consolidated fiscal year to ¥363.431 million, with the valuation impact of price fluctuations in held investment securities actually materializing. - FY2018WorsenedAnnual report
「Holdings at the end of the consolidated fiscal year ¥1,349 million」
Holdings of marketable shares and other securities increased from approximately ¥1,195 million at the end of the previous consolidated fiscal year to ¥1,349 million, expanding the amount exposed to the impact of falling prices. - FY2018-Q3WorsenedAnnual report
「Investments in securities 1,423,249」
The balance of investment securities was ¥1,423.249 million, an increase of ¥228.607 million from ¥1,194.642 million at the end of the previous consolidated fiscal year. The amount exposed to the impact of falling prices increased further. - FY2018-Q2WorsenedAnnual report
「Investments in securities 1,387,420」
The balance of investment securities increased from ¥1,194.642 million at the end of the previous consolidated fiscal year to ¥1,387.420 million, expanding the amount exposed to market price fluctuations. - FY2017WorsenedAnnual report
「As a rule, the Group holds marketable shares and other securities at the request of business partners and others with which it has business relationships, with holdings of ¥1,194 million at the end of the consolidated fiscal year. If share prices or other market prices fall substantially in the future, impairment losses may arise」
Holdings of marketable shares and other securities increased from ¥980 million at the end of the previous fiscal year to ¥1,194 million, expanding the amount exposed to impairment risk if share prices fall. - FY2017-Q1MaterialisedAnnual report
「Sharp market fluctuations, including a stronger yen and falling share prices, occurred after the United Kingdom decided to leave the EU in a referendum, among other effects.」
The disclosure states that a market price fluctuation in the form of falling share prices occurred. However, this quarterly report does not state that any impairment loss on investment securities was recognized. - FY2016First statedAnnual report
「As a rule, the Group holds marketable shares and other securities at the request of business partners and others with which it has business relationships, with holdings of ¥980 million at the end of the consolidated fiscal year. If share prices or other market prices fall substantially in the future, impairment losses may arise, adversely affecting the Group's results and potentially lowering its equity ratio.」
The disclosure shows the holdings of marketable shares and other securities, as well as the possibility of impairment losses and a lower equity ratio if share prices fall.